itraconazole has been researched along with Fever of Unknown Origin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hidaka, M; Kaneko, Y; Miyazaki, Y; Nagai, H; Saito, AM; Sawamura, M; Tanaka, S; Uike, N; Yoshida, I; Yoshida, S | 1 |
| Aguilera-Alonso, D; García Mancebo, J; Navarro, ML; Rincón-López, EM | 1 |
| da Cunha, JS; Freitas, L; Julião, M; Lebre, A; Malcata, L; Marques, F; Marques, N; Rabadão, E | 1 |
| Häussinger, D; Müller-Stöver, I; Richter, J; Tintelnot, K | 1 |
| Laferl, H; Pongratz, P; Stanek, G; Strau, G; Wenisch, C | 1 |
| Aulitzky, WE; Bammer, S; Binder, C; Böhme, A; Egerer, G; Ehninger, G; Glasmacher, A; Sandherr, M; Schuler, U; Schwerdtfeger, R; Silling, G; Wandt, H | 1 |
2 trial(s) available for itraconazole and Fever of Unknown Origin
| Article | Year |
|---|---|
Efficacy of Intravenous Itraconazole Versus Liposomal Amphotericin B as Empirical Antifungal Therapy in Hematological Malignancy with Persistent Fever and Neutropenia: Study Protocol for a Multicenter, Prospective, Randomized Non-inferiority Trial.
Topics: Amphotericin B; Antifungal Agents; Equivalence Trials as Topic; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Itraconazole; Multicenter Studies as Topic; Neutropenia; Prospective Studies; Randomized Controlled Trials as Topic | 2021 |
Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Cross-Over Studies; Empiricism; Female; Fever of Unknown Origin; Germany; Hematologic Neoplasms; Humans; Infusions, Intravenous; Itraconazole; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Patient Dropouts; Treatment Outcome | 2007 |
4 other study(ies) available for itraconazole and Fever of Unknown Origin
| Article | Year |
|---|---|
Imported Acute Histoplasmosis in an Adolescent with Suspected Lymphoproliferative Syndrome.
Topics: Adolescent; Antibodies, Fungal; Antifungal Agents; Diagnosis, Differential; Diagnostic Errors; Fever of Unknown Origin; Histoplasma; Histoplasmosis; Humans; Immunocompetence; Itraconazole; Lung Diseases, Fungal; Lymphadenopathy; Lymphoproliferative Disorders; Male; Mexico; Tomography, X-Ray Computed; Travel-Related Illness | 2019 |
Isolated oral histoplasmosis presenting as Fever of unknown origin in a Portuguese hemodialysis patient.
Topics: Amphotericin B; Antifungal Agents; Fever of Unknown Origin; Gingiva; Histocytochemistry; Histoplasmosis; Humans; Itraconazole; Male; Portugal; Renal Dialysis | 2013 |
[A 55-year-old woman with cough, fever, swelling of joints, and exanthema after a trip to Ecuador].
Topics: Antifungal Agents; Arthritis; Complement Fixation Tests; Cough; Ecuador; Exanthema; Female; Fever of Unknown Origin; Histoplasmosis; Humans; Itraconazole; Middle Aged; Travel | 2014 |
Coughing and fever after surfing in Central America.
Topics: Adult; Antifungal Agents; Central America; Cough; Diagnosis, Differential; Fever of Unknown Origin; Histoplasmosis; Humans; Itraconazole; Lung Diseases, Fungal; Male; Swimming; Therapeutics | 2012 |